REVATIO for Pulmonary hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 153 adverse event reports in the FDA FAERS database where REVATIO was used for Pulmonary hypertension.
Most Reported Side Effects for REVATIO
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 79 | 18.2% | 79 | 3 |
| Pulmonary hypertension | 44 | 10.1% | 39 | 10 |
| Dyspnoea | 41 | 9.5% | 6 | 14 |
| Cardiac failure | 26 | 6.0% | 19 | 6 |
| Fall | 21 | 4.8% | 2 | 10 |
| Pneumonia | 20 | 4.6% | 10 | 9 |
| Malaise | 17 | 3.9% | 1 | 6 |
| Cardiac disorder | 14 | 3.2% | 6 | 3 |
| Respiratory failure | 13 | 3.0% | 13 | 4 |
| Fluid retention | 11 | 2.5% | 1 | 10 |
| Hypotension | 10 | 2.3% | 4 | 6 |
| Off label use | 10 | 2.3% | 5 | 2 |
| Chronic obstructive pulmonary disease | 9 | 2.1% | 5 | 1 |
| Myocardial infarction | 9 | 2.1% | 5 | 1 |
| Cardiac failure congestive | 8 | 1.8% | 7 | 3 |
Other Indications for REVATIO
Other Drugs Used for Pulmonary hypertension
AMBRISENTAN (18,885)
TREPROSTINIL (10,034)
MACITENTAN (5,228)
RIOCIGUAT (3,837)
SILDENAFIL (3,761)
SELEXIPAG (2,500)
EPOPROSTENOL (2,486)
TADALAFIL (2,430)
BOSENTAN (2,337)
ILOPROST (1,123)